MeSH term
Frequency | Condition_Probility | Cell Line | 4 | 0.0 |
Disease Progression | 3 | 0.0 |
Down-Regulation | 4 | 0.0 |
Humans | 50 | 0.0 |
Male | 22 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Receptors, Fibroblast Growth Factor/genetics/*metabolism | 3 | 8.0 |
Reference Values | 2 | 0.0 |
Mice | 7 | 0.0 |
Mice, Nude | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 20 | 0.0 |
Tumor Cells, Cultured | 12 | 0.0 |
Epithelium/embryology | 2 | 11.0 |
Exons/genetics | 2 | 0.0 |
Fibroblast Growth Factors/*genetics | 2 | 4.0 |
Image Processing, Computer-Assisted | 2 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mesoderm/metabolism | 2 | 2.0 |
Receptors, Fibroblast Growth Factor/*genetics | 3 | 1.0 |
Transforming Growth Factor beta/*genetics | 2 | 2.0 |
Animals | 12 | 0.0 |
Cell Division/drug effects | 5 | 0.0 |
Female | 7 | 0.0 |
Fibroblast Growth Factors/*pharmacology | 2 | 4.0 |
Cell Differentiation | 2 | 0.0 |
Cell Division | 8 | 0.0 |
Gene Expression | 3 | 0.0 |
Receptor Protein-Tyrosine Kinases/*genetics/metabolism | 2 | 3.0 |
Receptors, Fibroblast Growth Factor/*genetics/metabolism | 2 | 9.0 |
Research Support, Non-U.S. Gov't | 26 | 0.0 |
Transfection | 5 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Cells, Cultured | 8 | 0.0 |
Recombinant Proteins/pharmacology | 4 | 0.0 |
Aging/metabolism | 2 | 1.0 |
Infant | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Receptors, Fibroblast Growth Factor/*metabolism | 3 | 5.0 |
Blotting, Northern | 3 | 0.0 |
Blotting, Western | 4 | 0.0 |
Comparative Study | 3 | 0.0 |
Fibroblast Growth Factor 1/metabolism | 3 | 42.0 |
Fibroblast Growth Factors/*metabolism | 5 | 12.0 |
Protein Binding | 5 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
COS Cells | 2 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Aged | 3 | 0.0 |
Fibroblast Growth Factor 2/*biosynthesis | 2 | 9.0 |
Fibroblast Growth Factors/*biosynthesis | 2 | 28.0 |
Middle Aged | 3 | 0.0 |
Prostatic Hyperplasia/*metabolism | 2 | 4.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Fibroblast Growth Factors/*physiology | 3 | 15.0 |
Receptors, Fibroblast Growth Factor/*physiology | 2 | 22.0 |
Signal Transduction/*physiology | 2 | 0.0 |
DNA, Complementary/*analysis | 2 | 9.0 |
*Gene Expression Profiling | 3 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Androgens/*physiology | 2 | 4.0 |
Epithelium/physiology | 2 | 2.0 |
Mesoderm/physiology | 2 | 5.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Fibroblast Growth Factor 2/metabolism | 4 | 4.0 |
Models, Biological | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Molecular Sequence Data | 7 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Up-Regulation | 4 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 2 | 3.0 |
Receptors, Fibroblast Growth Factor/genetics/metabolism | 2 | 8.0 |
Adult | 4 | 0.0 |
Prostate/cytology/drug effects/*metabolism | 2 | 50.0 |
Prostatic Neoplasms/metabolism | 2 | 3.0 |
*Fibroblast Growth Factors | 12 | 13.0 |
Growth Substances/*metabolism | 3 | 2.0 |
Receptors, Fibroblast Growth Factor/*biosynthesis/genetics | 2 | 18.0 |
Paracrine Communication/*physiology | 2 | 11.0 |
Prostatic Hyperplasia/metabolism | 2 | 6.0 |
Prostatic Neoplasms/*metabolism/pathology | 2 | 2.0 |
Base Sequence | 4 | 0.0 |
DNA Primers/chemistry | 2 | 0.0 |
Crystallography, X-Ray | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Exons | 3 | 0.0 |
Hydrogen Bonding | 2 | 1.0 |
Ligands | 3 | 0.0 |
Fibroblast Growth Factors/genetics | 2 | 5.0 |
Receptors, Fibroblast Growth Factor/genetics | 2 | 3.0 |
Fibroblast Growth Factors/metabolism | 3 | 5.0 |
Sequence Deletion | 2 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
